Maarten van der Doelen

Patient-reported outcomes in mCRPC patients treated with radium-223 therapy

Painful sites

Pain characteristics

1-3

4-5

6 injections

1-3

4-5

6 injections

60

60

40

40

20

20

Mean score

Mean score

0

0

T0

T1

T2

T0

T1

T2

Time point

Time point

Functional interference

Psychosocial aspects

100

100

1-3

4-5

6 injections

1-3

4-5

6 injections

4

80

80

60

60

Mean score

Mean score

40

40

20

20

T0

T1

T2

T0

T1

T2

Time point

Time point

Supplementary figure 7. Course of bone metastases-related health-related quality of life (EORTC BM-22 functional and symptom scales) over time in patients treated with radium-223 for metastatic castration resistant prostate cancer. Bars indicate mean scores with 95% confidence intervals.

115